Table 1 Summary of the datasets used for cross-validation in our study.

From: Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets

Study Platform Technology Country Data normalization miRNA in platform Sample # Cancer # Normal #
GSE10694 GPL6542 Microarray China Quantile normalization 119 156 78 78
GSE31384 GPL14140 Microarray China Quantile normalization 525 166 166 0
TCGA Illumina miRNA-Seq USA Reads per million miRNA mapped data 412 421 372 49
GSE6857 GPL4700 Microarray USA Median normalization 209 481 241 240
845 unique miRNAs 1,224 857 367